|Previous Section||Index||Home Page|
19 Sept 2002 : Column 349Wcontinued
David Taylor: To ask the Secretary of State for Health what discussions he has had concerning the European Commission's draft regulation on official controls on Products of Animal Origin; and if he will make a statement. 
Ms Blears [holding answer 17 June 2002]: The European Commission's proposal for a Regulation on official controls on products of animal origin is currently under discussion. The first meeting in Council Working Group took place between 23 and 24 July 2002. The Food Standards Agency (FSA) is leading negotiations on behalf of the UK. The FSA will be writing to stakeholders to advise them of the issues arising following this meeting and a copy of this letter will be placed in the Library.
19 Sept 2002 : Column 350W
Mr. Kaufman: To ask the Secretary of State for Health when he intends to reply to the letter to him dated 3 May from the right hon. Member for Manchester, Gorton with regard to Mr. A. Starkie. 
Mr. Andrew Turner: To ask the Secretary of State for Health when he will reply to the letters from the hon. Member for the Isle of Wight (Mr. Turner) dated 4 February and 22 April to the Under-Secretary of State for Health, the hon. Member for Salford (Ms Blears); and what the reason is for the delay in replying. 
The Government are determined to continue to make reducing delayed discharge a priority area. This is the key to getting the right care, in the right place, at the right time for all patients. Under this year's budget, overall social services funding will increase by six per cent. and we intend to bring forward legislation to ensure that good partnership working between the National Health Service and local authority social services reduces the number of delays even further.
Mr. Hutton: My right hon. Friend the Chancellor of the Exchequer's Budget statement on 17 April 2002 announced unprecedented annual average increases for the National Health Service in England of 7.3 per cent. per annum over five years from 200304 to 200708, on the basis of stage 1 resource budgeting. This is the level of increase recommended by the Wanless report under its "fully engaged" scenario. We are currently considering how best to take forward the other recommendations of the Wanless report.
19 Sept 2002 : Column 351W
Mr. Burstow: To ask the Secretary of State for Health what plans he has to undertake further work as part of a whole systems approach to analysing and modelling health and social care as set out in the Wanless report, paragraph 1.12. 
Mr. Randall: To ask the Secretary of State for Health if a hospital previously scheduled to be built under a PFI scheme will be eligible to apply for partial funding under the diagnostic and treatment centre funding programme. 
Mr. Hutton: We are committed to an ambitious programme of new Diagnosis and Treatment Centres (DTCs). Some are on course to be developed as part of PFI projects, others through the use of public capital. We expect local National Health Service authorities to develop proposals based on sources of funding which offer the best value for money and speed of implementation. The ability to provide public funding for a part of a PFI scheme will depend on the degree of separability (and inter-dependence) of the DTC elements from the rest of the scheme.
Mr. Bellingham: To ask the Secretary of State for Health how long he estimates it would have taken to complete the tendering process for the smallpox vaccine order if the usual tendering process had been used. 
Mr. Hutton: If the usual open tendering processes had been used for the procurement of smallpox vaccine, the complete process is likely to have taken as long as four to five months to complete. Potential suppliers must first submit an expression of interest in response to the 37-day advertisement in the Official Journal of European Communities and must accompany that expression with evidence requested by the contracting organisation. From those who satisfy this first stage, tenders would be invited from some or all, and a period of 40 days is usually allowed for potential bidders to submit bids. There then follows a period during which the tenders are evaluated, terms agreed and a contract is prepared.
19 Sept 2002 : Column 352W
by his Department since 1997, indicating for each consultation (a) if copies were available online, (b) if copies were available in print, (c) the date the time period given for responses opened and (d) the date the time period given for responses closed. 
Mr. Lammy: Data are only available from 2001 onwards. All consultation material is available ion printed form by request to the Department and all consultations are posted on the Department's website. Details of the consultations undertaken since 2001 were provided in the answer give to the hon. Member for the Isle of Wight (Mr. Turner) on Tuesday 23 July 2002, Official Report, column 1096W.
Mr. Bercow: To ask the Secretary of State for Health if he will list the public consultations undertaken by his Department since 8 June 2001, indicating the (a) length and (b) number of responses received in each case. 
Mr. Paul Marsden: To ask the Secretary of State for Health what the underlying reasons are for the change in the number of finished consultant episodes between 1997 and 2001 for the treatment of (a) malignant neoplasm of lip, (b) Kaposi's sarcoma, (c) leukaemias of specified and unspecified cell types, (d) carcinoma in situ of cervix uteri, (e) benign neoplasm of mouth and pharynx and (f) benign neoplasm of bone and articular cartilage; and if he will make a statement. 
Ms Blears: The figures for finished consultant episodes in 199697 and 200001 are shown in the table. The hospital episode statistics database does not hold any information on underlying reasons for the change in figures.
|Malignant neoplasm of lip||448||399|
|Leukaemias of specified and unspecified cell types||1,421||1,109|
|Carcinoma in situ of cervix uteri||13,955||10,835|
|Benign neoplasm of mouth and pharynx||2,551||2,429|
|Benign neoplasm of bone and articular cartridge||2,134||2,054|
An FCE is defined as a period of patient care under one consultant in one health care provider. The figures do not represent the number of patients, as one person may have several episodes within the year.
The primary diagnosis is the first of seven diagnosis fields in the HES data set, and provides the main reason why the patient was in hospital.
Data for 199697 are adjusted for both coverage and unknown/invalid clinical data; 200001 figures are not yet adjusted for shortfalls.
Hospital Episode Statistics (HES), Department of Health
|Next Section||Index||Home Page|